Cleared Traditional

K201048 - SherpaPak Pediatric Liver Transport System (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201048 · Paragonix Technologies · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
72d
Days
Class 2
Risk

K201048 is an FDA 510(k) clearance for the SherpaPak Pediatric Liver Transport System. Classified as System, Perfusion, Kidney (product code KDN), Class II - Special Controls.

Submitted by Paragonix Technologies (Braintree, US). The FDA issued a Cleared decision on July 2, 2020 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5880 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Paragonix Technologies devices

Submission Details

510(k) Number K201048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2020
Decision Date July 02, 2020
Days to Decision 72 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 130d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KDN System, Perfusion, Kidney
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDN System, Perfusion, Kidney

All 41
Devices cleared under the same product code (KDN) and FDA review panel - the closest regulatory comparables to K201048.
BAROguard Donor Lung Preservation System
K254305 · Paragonix Technologies, Inc. · Jan 2026
EasiSlush® Sodium Chloride Solution for Sterile Slush Preparation (BTLE-1250)
K243618 · Bridge TO Life · Jun 2025
X°Port Lung Preservation System
K243870 · Traferox Technologies, Inc. · May 2025
DCX Disposable Cassette (DCX)
K243998 · Institut Geroges Lopez · Apr 2025
Belzer UW® Cold Storage Solution (BTLBUW-001)
K243384 · Bridge TO Life · Mar 2025
Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)
K243840 · Bridge TO Life · Mar 2025